The formation of carcinogen-DNA adducts within the respiratory epi thelium is thought to be a critical factor in the induction of lung cancer from tobacco smoke. A reliable surrogate measure of carcinogen damage to the lung would be of great value in molecular epidemiological studies of cancer risk. The validity of measurements of DNA adducts formed from hydrophobic aromatic hydrocarbons in peripheral blood mononuclear cells IMNCs) was investigated by comparing the levels of aromatic DNA adducts detected in lung tissue from 31 lung cancer patients with those detected in MNCs from the same individuals using the 32P-postlabeling assay. The associations of smoking history and intake of dietary antioxidants with adduct levels also were assessed. Tissue-specific, as well as common DNA adducts were detected in lung and blood; total MNC adduct levels were highly correlated with total lung adducts. After smok ing cessation, adduct levels appeared to decay in both tissues at similar rates. Multivariate analyses (Poisson regression modeling) indicated that dietary antioxidant intake (carotenoids, vitamin A, and retinol) modified the levels of aromatic DNA adducts in both the lungs and blood. Of all models tested, the optimal one for predicting lung adduct levels included the measure of blood MNC adduct levels only. Therefore, blood MNCs are a valid surrogate tissue for estimating the burden of DNA adducts in respiratory tissue in molecular epidemiological studies.
INTRODUCTION
Epidemiological studies have established the causal link between tobacco smoking and the lung cancer epidemic of the 20th century (1â€"3). Recent studies indicate the evolving nature of the epidemic, and new approaches that incorporate molecular markers have been pro posed to address these new challenges for lung cancer prevention and control. Decreases in tobacco consumption in middle-aged males have led to decreases in lung cancer mortality (4) (5) (6) ; former smokers, however, may be at excess risk for up to 30 years after smoking cessation (7) . Increases in smoking among women have been associ ated with striking increases in lung cancer incidence and mortality (8) . Dramatic shifts in the histological type and location of lung tumors have occurred during the last two decades (9) . Life-style factors, including changes in dietary fat or antioxidant intake, also could affect future trends in lung cancer mortality (10, 11) .
Biomarkers of the biologically effective dose of tobacco carcino gens within the respiratory epithelium figure prominently in molecu lar studies of lung carcinogenesis. These markers estimate the forma tion of stable complexes of tobacco carcinogens with DNA, which are thought to be a crucial step in cancer induction (12, 13) . The most widely studied class of smoking-induced DNA adducts is derived from polynuclear aromatic hydrocarbons. Hydrophobic aromatic DNA adducts detected by the ultrasensitive 32P-postlabeling assay have been identified in tissues obtained at surgery or autopsy that are known targets of tobacco smoke carcinogenesis: lung, bronchus, larynx, oral cavity, and bladder (14) (15) (16) (17) (18) (19) (20) (21) (22) (23) (24) . Smoking exposure indices such as the cumulative pack/year history of tobacco use among current smokers have been found to be correlated linearly with aro matic DNA adduct levels in human lung (14, 16, 25) and bronchus (15) . After smoking cessation, aromatic DNA adduct levels decrease in lung (26) , although the kinetics of the disappearance of these lesions have not been well characterized.
A crucial issue for molecular epidemiologists is the validity of surrogate tissue sources of DNA adducts that are obtained from the general population. Previous attempts to validate peripheral blood white cells as a surrogate tissue source for lung adduct determinations used DNA isolated from total white blood cells. Approximately 70% of total white blood cells are short-lived granulocytes, whereas the remaining 30% are longer-lived MNCs.3 Total white blood cell aro matic DNA adduct levels were found to be associated neither with active cigarette smoking (14, 16, 26) nor with adduct levels measured in lung tissue from the same individuals (27) . In other studies, how ever, aromatic DNA adduct levels from MNCs were found to be increased in current smokers (28) and were reproducibly measured by the 32P-postlabeling assay over time (29) . Consequently, we propose that long-lived MNCs should be a valid surrogate tissue for assessing chronic exposure to tobacco carcinogens.
MATERIALS AND METHODS
Surgically resected noninvolved lung tissue was obtained from patients (21 male and 10 female) undergoing surgery for histopathologically confirmed lung cancer. The protocol used was approved by the Committees on the Use of Human Subjects in Research at the Massachusetts General Hospital and the Harvard School of Public Health (Boston, MA). Tissue specimens were frozen immediately on dry ice and maintained frozen at -70Â°C until DNA adduct studies. Blood samples (30 ml heparinized whole blood) were obtained from each subject and applied to Ficoll-Hypaque density gradients to separate MNCs from erythrocytes and granulocytes. In addition, a questionnaire was administered to each patient, eliciting information on his or her smoking history, occupation, and other demographic factors. Detailed dietary histories were collected using the Harvard-Willett food frequency questionnaire (30) .
Frozen tissues or MNCs were homogenized in 0.1 MTris, 0.1 MNaCl, 5 mM EDTA (pH 8.0), and 10% SDS on ice and then extracted twice with equal volumes of chloroform:isoamyl alcohol (24:1). The aqueous supernatant was incubated with RNase A and RNase Tl (250 u.g/ml, Sigma Chemical Co.) at 37Â°Cfor 60 min followed by digestion with proteinase K (10 /ig/ml, Merck) at 37Â°Cfor 60 min. The digest was extracted twice with chlorofornrisoamyl alcohol, then sodium acetate (4.0 M final solution) was added to the aqueous supernatant. DNA was precipitated with ethanol at â€"¿ 4Â°C and dissolved in water. The quantity of DNA was determined by a fluorometric method. The 32P-postlabeling method has been described (31 bisphosplates was applied to each 10 X 10 cm polyethyleneimine cellulose plate. Plates were developed overnight in l M NaH2PO4 (pH 6), and the plates were washed twice (7 min) with H2O, followed by a 10-min wash in 0.15 M ammonium formate (pH 3.5). The plates were air dried and developed in 3.0 M lithium formate and 7.0 M urea (pH 3.5) from the bottom to the top of the plate. The plates were then washed twice (7 min) in H2O, air dried, and developed at a right angle to the previous direction of development in 0.72 M NaH2PO4, 0.45 M Tris-HCl, and 7.6 M urea (pH 8.2). The plates were then washed twice with H2O and subsequently developed in the same direction with 1.7 M NaH2PO4 (pH 6.O.) The adducts were located by autoradiography using Kodak XAR-5 film (Eastman Kodak) and a Dupont Chronex-Lightning Plus intensifying screen (DuPont-NEN). The film was exposed at -70Â°C for 3-4 days. The areas of the radioactive spots on the polyethyleneimine cellulose sheets were measured, and the spots were then scraped into liquid scintillation vials containing 5 ml scintillation mixture (Safety Solve; Research Products, Inc.); radioactivity was determined by liquid scintillation counting. Regions adjacent to the radioactive spots of equal area also were scraped, placed into scintillation vials, and counted for background determination. Adduci levels were corrected for background counts after adjusting for the area of the TLC sample. The level of modification was calculated as described. For example, assuming that 4 jxg of DNA = 1.21 X IO4 pmol of 3'-deoxynucleotide monophosphates and that the specific activity of the [32P]ATP is 9.36 X IO6 cpm/pmol, adduci levels were calculated as follows: relative adduci level (RAL) = cpm in adducts/11.32 X 10"' cpm. Table 1 summarizes the characteristics of the 31 lung cancer cases; of significance is the fact that 50% of the subjects were former smokers who had not smoked for at least 1 year. The average time since smoking cessation in these subjects was nearly 15 years. Despite the length of time since active smoking, all subjects had detectable levels of lung aromatic DNA adducts (i.e., above the limit of detec tion, which is 1 adduct/10'0 nucleotides). Samples used for DNA adduci sludies were uninvolved Â¡issuesadjacent to the tumor. Because of variations in the sizes of the resected tissue, the specimens varied in size (0.2-2.0 g). No correlation was observed between the size of the sample and the resultant DNA adduci level (data not shown). Although no attempt was made to correlate adduci values with the anatomic location of the tissue samples, we did analyze adduci values in relationship to tumor histology and found no association of cell type with DNA adduci levels.
RESULTS
A diffuse band of radioactivity, the DRZ, and discrete adducts were observed (Fig. 1) . The struclures of the individual adducts were noi delermined. However, we developed a composite adduci map (Fig.  \A) and assigned the same adduci number lo Chromatographie spots, which, when reisolated, cochromatographed in several differenl buffer syslems lo ihe same localion or region. Overall, total relative adduci values (DRZ plus discrele adducts) were 2.5-fold higher in lung compared with blood MNCs (Table 1) . However, these differences belween tissues cannot be considered absolule, because the labeling efficiencies and recoveries of Ihe adducls delected are not known. Among the nine discrete adducts that were detected, tissue-specific associations were noted. Adducts that chromatographed to regions 3, 4, and 5 were not detecled in any MNC analyses; adducls in the regions 7, 8, and 9 were detected only in MNCs; and adducts observed in regions 1, 2, and 6 were found in both lung and MNC samples.
The DNA adduci found in region 2, which was found in both lung and blood MNCs, cochromatographed with '12P-labeled ( + )-anti-BPDE-N2-dGuanine. This is the major stable adduci formed from benzo(a)pyrene in many cells and lissues, including human blood MNCs (31) . Adducls in regions 3, 4, and 5 cochromatographed with DNA isolated from MNCs treated with benzo(Â«)pyrene-4,5-oxide (31) . DNA adducts with Chromatographie properties similar to ihose of adducls observed in regions 3, 4, and 5 also have been isolaled from Ihe lung of 9-hydroxy-benzo(a)pyrene-trealed rals; Ihese adducts were poslulaled to be derived from the 4,5-epoxide of 9-hydroxybenzo(a)pyrene (32) .
Initial analysis indicated a significan! correlalion between tolal aromalic DNA adducls in blood MNCs and total adduci levels in lung (Spearman's correlalion r = 0.74; P < 0.001; Fig. 2 ). We lesled whether individual blood DNA adducts or combinations showed a stronger association with tolal lung adduci levels than the total blood adduci value. None of the individual blood adduci indices correlated more highly with lolal lung adducls than did total blood adduci level. Of Â¡merest,however, was a significanl correlation of MNC-specific adducts with lung adducts. For example, the sum of MNC adducts in regions 7, 8, and 9 correlated well with tolal lung adducls (Spearman's correlalion r = 0.54; P < 0.002) and with lung specific adducts in regions 3, 4, and 5 (Spearman's correlation r = 0.76; P < 0.001).
Because so many of the subjects were former smokers, and because aromatic DNA adducts have been shown to decrease after smoking cessalion, we examined lung and blood adduci levels in relalion to years since smoking cessation. Fig. 3 illuslrutes Ihe cross-sectional analysis of adduci levels in former smokers. The dala suggesl a rapid decrease in adduci levels in bolh lung and blood within the first 2 years after smoking cessation, allhough DNA adducts were deteclable even in individuals who had quit smoking 40 years before our study. Although all data comparing lung and blood adduci levels are derived from smokers, three additional lung samples were obtained from lung cancer patienls who reported never smoking tobacco. Very low adduci levels were found in lung specimens from never-smokers; lolal adduci values of 37, 3, and 50 adducls/101" nucleolides were observed for the three subjects. The relalively low adduci values in never-smokers is consislenl wilh the idea thai the majority of adducts detected in the 31 current and former smokers are smoking-related.
To lesi whether dietary inlake of antioxidants affects lung DNA adduci levels and lo compare Ihese effecls with adduci levels in blood, we performed multivariale analyses lhal controlled for intensity of recent smoking and Ihe lime since smoking cessation in former smokers. These analyses were carried out after tesling for polential effecls of the patients' age, sex, or tumor histology, none of which were associaled wilh adduci levels. variables identified (cigarettes/day during the last year and years since smoking cessation) were entered into Poisson regression models (33) with a series of antioxidant variables: total vitamin A, retinol, carotenoids (those with provitamin A activity), vitamin C, and vitamin E. Stepwise elimination of variables yielded carotenoid intake as the most significant independent variable in the lung. Vitamin A and retinol, which were highly correlated with carotenoids, also were significant in the lung and when the same model was applied to the blood MNC data. Vitamins C and E were the least significant in the lung, although, in the blood model, vitamin E was highly significant (data not shown). Table 2 illustrates the similarity in both direction and magnitude of the regression coefficients for years since smoking cessation, and carotenoid intake in the lung and blood models. 
DISCUSSION
Molecular epidemiology has been proposed to be an important adjunct to conventional studies that will provide the basis for under standing the role of environmental tobacco smoke in lung cancer (34) , the efficacy of chemoprevention and dietary interventions (35) , and the contribution of genetic susceptibility (36, 37) in smoking-related cancers. Our results indicate that DNA adducts measured by 32P-postlabeling in blood MNCs may be a useful marker to address these issues. Our finding of a positive correlation between blood and lung adduci levels suggests that MNCs are a valid surrogate for the lung. Recent studies indicate that a large fraction of blood lymphocytes, which represents approximately 70-90% of the MNC fraction, mi grates to the lung and slowly redistributes to peripheral blood and other tissues (38, 39) . Such intimate contact with the pulmonary capillary network would be expected to result in significant exposure of lymphocytes to inhaled tobacco carcinogens. The dose to these cells would not be expected to be as great as that to the directly exposed respiratory epithelium. In addition, blood MNCs may express a distinct complement of metabolic activities toward tobacco carcin ogens (40, 41) . Therefore, blood MNCs exposed in vivo could be expected to produce a cell-specific pattern of reactive electrophiles and DNA adducts. These observations may help to explain the major findings of our studies: (a) Aromatic DNA adduci levels in blood MNCs, although lower in concentration, were highly correlated with levels in lung; and (b) tissue-specific patterns of adducts were ob served; however, MNC-specific adducts still correlated with the lung measurements. The fact that MNCs are longer-lived cells than are blood granulocytes may explain why we observed positive correla tions between blood and lung adduci levels, whereas earlier studies, in which total white cells were used, reported no significant associalions (17) . Short-lived granulocytes, which are Ihe predominant nucleated cell type within whole blood, may not persist long enough to accu mulate detectable levels of smoking-related DNA adducts. The higher relative adduci levels in lung compared with while blood cells is 4912 Differences in adduci levels between tissues also could be attributed to differences in the efficiency of phosphorylation of tissue-specific DNA adducts. To address these issues, additional characterization of the chemical structures of tobacco-related DNA-adducts is required, and new analytical strategies must be developed (21) . Perhaps the most important determinant of individual differences in DNA adduci levels uncovered in this study was the time since smok ing cessation in former smokers. The negative correlation between adduci levels and smoking cessation is consistent with previous stud ies (26) and supports the notion that DNA adducts are related to lung cancer risk, because epidemiological studies have demonstrated de creases in risk after smoking cessation. Cross-sectional studies, such as this one, are limited in their ability to define the rate of loss of adducts from the lung. Longitudinal studies of lung DNA adducts, however, are not feasible, given the requirement for repeated invasive procedures, such as lung biopsy. The apparent similarity in the kinet ics of decay of aromatic DNA adducts in lung and MNCs that we observed indicates that longitudinal studies using blood DNA adduci levels, which are less invasive, may be useful for estimaling the kinetics of adduci loss in lung after smoking cessalion. In long-lerm former smokers, low levels of DNA adducls were deleclable even decades after smoking cessalion. Allhough Ihese adducts could rep resent highly persistenl forms of smoking-relaled DNA damage, they also may arise from sources other lhan cigarette smoking. Consump tion of charbroiled food has been shown lo modify polycyclic aro matic hydrocarbon-DNA adduci levels in peripheral white blood cells (43); we did not assess the recent consumplion of dielary sources of polycyclic aromatic hydrocarbons in this study.
In addition to intensity and duration of smoking, a number of studies indicale lhal inlake of dielary anlioxidanls modifies lung cancer risk (10, 11) . One postulated mechanism for this associalion is lhal anlioxidanls decrease Ihe induclion of DNA damage by tobacco carcinogens (44) . Molecular epidemiological studies aimed at underStanding the role of diel in lung carcinogenesis musi use surrogate markers of lung damage lhal respond to differences in antioxidant inlake and cigarelle consumplion and lhat accurately reflecl Ihe modificalion of DNA damage wilhin Ihe lung thai is associated with these differences. This study indicates that blood MNC DNA adduci levels meel Ihese criteria. Our multivariate analyses (Table 2 ) indicated a similarily in Ihe exlenl of modificalion of adduci levels by diet and smoking cessation in the target and surrogate tissue. In addition, il is not unexpected that the regression coefficient for the recent smoking term (i.e., cigareltes/day) is positive in sign and of greater magnilude in the lung than in blood. In all subjects, lung adduci levels were higher lhan blood adducls, which likely reflecls the higher dose of tobacco carcinogens to Ihe respiratory epilhelium. Allhough the va lidity of MNC DNA adducts as markers of Ihe effects of dietary anlioxidanls on lung DNA damage requires addilional study, these results are consistenl with Ihe epidemiological data that indicate that intake of carolenoids, vilamin A, and foods conlaining Ihese nulrienls are slrongly associated wilh decreased lung cancer risk (10, 11) . Other researchers, who used an ELISA method to measure DNA adducts, found an inverse correlation of adduci levels in white blood cells with serum anlioxidanl levels bui noi wilh self-reported dietary inlake (45) . Differences in Ihe analylic sensilivity and specificily of adduci deleclion by immunological melhods and Ihe 32P-posllabeling assay lhal influence assessmenl of dielary antioxidants warranl addilional sludy. In any case, Ihis sludy indicates lhat blood MNC adduci levels may prove lo be useful as markers for chemoprevenlion and diel intervenlion studies of individuals at high risk for lung cancer. The correlation of blood MNC adduci levels with lung levels was found to not be improved by assessment of dietary intake of antioxidanls, even in combinalion with smoking variables that reflected lime since smoking cessalion and receÃ±Ã-tobacco consumplion. These resulls indicate lhal lolal MNC adduci levels are a useful marker of tobacco-induced DNA damage in Ihe lung and should be further evaluated as a polenlial tool for the assessment of individual lung cancer risk in molecular epide miological sludies. 
